Farther Finance Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.2K | Buy |
843
+509
| +152% | +$11K | ﹤0.01% | 2737 |
|
|
2025
Q1 | $5.45K | Hold |
334
| – | – | ﹤0.01% | 3016 |
|
|
2024
Q4 | $6.13K | Buy |
334
+45
| +16% | +$826 | ﹤0.01% | 2575 |
|
|
2024
Q3 | $4.45K | Hold |
289
| – | – | ﹤0.01% | 2690 |
|
|
2024
Q2 | $4.64K | Sell |
289
-1,455
| -83% | -$23.3K | ﹤0.01% | 2428 |
|
|
2024
Q1 | $31.8K | Hold |
1,744
| – | – | ﹤0.01% | 1343 |
|
|
2023
Q4 | $54.6K | Buy |
1,744
+1,490
| +587% | +$46.7K | ﹤0.01% | 1006 |
|
|
2023
Q3 | $5.29K | Hold |
254
| – | – | ﹤0.01% | 1502 |
|
|
2023
Q2 | $6.08K | Hold |
254
| – | – | ﹤0.01% | 1358 |
|
|
2023
Q1 | $4.78K | Hold |
254
| – | – | ﹤0.01% | 1356 |
|
|
2022
Q4 | $4.04K | Buy |
+254
| New | +$4.04K | ﹤0.01% | 1238 |
|